(19)
(11) EP 3 548 464 A1

(12)

(43) Date of publication:
09.10.2019 Bulletin 2019/41

(21) Application number: 17825118.7

(22) Date of filing: 29.11.2017
(51) International Patent Classification (IPC): 
C07C 319/02(2006.01)
A61K 31/00(2006.01)
 A61K 9/19(2006.01)
C07C 323/25(2006.01)
(86) International application number:
PCT/EP2017/080881
(87) International publication number:
WO 2018/100008 (07.06.2018 Gazette 2018/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 30.11.2016 EP 16306582

(71) Applicants:
  • Clevexel Pharma
    75013 Paris (FR)
  • Institut Gustave Roussy
    94800 Villejuif (FR)

(72) Inventors:
  • WANG-ZHANG, Xiuping
    75013 Paris (FR)
  • PIVETTE, Perrine
    94140 Alfortville (FR)
  • GONZALEZ, Karine
    94700 Maisons Alfort (FR)
  • DEUTSCH, Eric
    75004 Paris (FR)
  • CLEMENSON, Céline
    91400 Orsay (FR)

(74) Representative: Agasse, Stéphane et al
Cabinet GERMAIN & MAUREAU B.P. 6153
69466 Lyon Cedex 06
69466 Lyon Cedex 06 (FR)

   


(54) PROCESS FOR THE PREPARATION OF FREEZE-DRIED 2-[(3-AMINOPROPYL)AMINO]ETHANETHIOL FORMULATION